Evidence map›Paper›PMID 28219517›Full record

ArticleOphthalmology2017

Re: Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group, et al.: Five-year outcomes with anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials (Ophthalmology 2016;123:1751-1761).

Mark C Gillies, Vincent Daien, Vuong Nguyen, Daniel Barthelmes

Erratum issuedAbstract readLetterComment
PubMed Publisher
In one paragraph

Article in Ophthalmology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Mark C GilliesThe Save Sight Institute, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia.
Vincent DaienThe Save Sight Institute, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia; Department of Ophthalmology, Gui De Chauliac Hospital, Montpellier, France. Electronic address: vincent.daien@sydney.edu.au.
Vuong NguyenThe Save Sight Institute, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia.
Daniel BarthelmesThe Save Sight Institute, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia; Department of Ophthalmology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Vascular Endothelial Growth Factor AWet Macular DegenerationAngiogenesis InhibitorsBevacizumabHumansMacular DegenerationRanibizumabAngiogenesis InhibitorsBevacizumabRanibizumabVascular Endothelial Growth Factor A

Identifiers

PMID28219517

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.